| Cases |
Controls |
Cohort(Click to view selection criteria for cases and controls) |
Ancestry |
|---|
| 782 |
2,785 |
Atherosclerosis Risk in Communities Study VTE cohort (ARIC)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c < 5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
| 27 |
863 |
Genetics of Cardiometabolic Health in the Amish (Amish)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c < 5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 14 |
293 |
Cleveland Clinic Atrial Fibrillation Study (CCAF)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 173 |
491 |
Cleveland Clinic Atrial Fibrillation Study (CFS)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
| 15 |
52 |
Cardiovascular Health Study (CHS)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 1,117 |
7,500 |
Genetic Epidemiology of COPD (COPDGene) in the TOPMed Program
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
| 293 |
18 |
Diabetes Heart Study (DHS)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
| 620 |
3,001 |
Framingham Heart Study (FHS)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 350 |
642 |
Genetic Epidemiology Network of Arteriopathy (GENOA)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
African |
| 59 |
708 |
Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 138 |
1,461 |
Genetic Epidemiology Network of Salt Sensitivity (GenSALT)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Asian |
| 198 |
1,351 |
Genetic Studies of Atherosclerosis Risk (GeneSTAR)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
| 4 |
59 |
Heart and Vascular Health Study (HVH)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 323 |
1,329 |
Hypertension Genetic Epidemiology Network (HyperGEN)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
African |
| 1,034 |
2,076 |
Jackson Heart Study (JHS)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
African |
| 1,022 |
3,766 |
Multi-Ethnic Study of Atherosclerosis (MESA)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
| 52 |
830 |
Massachusetts General Hospital Atrial Fibrillation Study (MGH_AF)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 16 |
88 |
Partners Healthcare Biorepository (Partners)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 232 |
781 |
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk - San Antonio Family Studies (SAFS)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Hispanic |
| 185 |
918 |
Samoan Adiposity Study (Samoan)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Samoan |
| 26 |
128 |
Vanderbilt Atrial Fibrillation Ablation Registry (VAFAR)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 172 |
812 |
Vanderbilt Genetic Basis of Atrial Fibrillation (VU_AF)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
European |
| 2,787 |
5,041 |
Women's Health Initiative (WHI)
| Case selection criteria |
Control selection criteria |
|---|
| Fasting glucose ≥ 7 mmol/L OR treatment OR HbA1c ≥ 6.5% OR 2-hr OGTT ≥11.1 mmol/L, OR random/non-fasting glucose ≥ 11.1 mmol/L OR physician diagnosis OR self-reported diabetes |
Fasting glucose < 5.6 mmol/L, AND HbA1c <5.7% (if available), AND 2-hr OGTT < 7.8 mmol/L (if available), AND Not on diabetes medication |
|
Mixed |
